DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Apr 26, 2024 · 2y ago · Accession 0001308179-24-000609
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Apr 26, 2024
- Report date
- Jun 18, 2024
- Document
- lrare2024_def14a.htm
- Size
- 4.9 MB